Post by OncoDaily GI

🔎 10 Must-Read Posts in GI Oncology | Third Week of January 2026 The third week of January 2026 brings together a focused and practice-shaping selection of discussions in GI oncology, spanning colorectal, pancreatic, hepatocellular, biliary cancers.  𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀 • HER2-targeted therapy in metastatic colorectal cancer (MOUNTAINEER) • Adjuvant CAPOX duration in colorectal cancer (SCOT trial) • iRGD plus PD-L1 inhibition in hepatocellular carcinoma • Early-onset colorectal cancer with BTC and PDAC epidemiology • Pancreatic cancer heterogeneity and translational tools • Registry-based colorectal cancer recurrence algorithms • Oligometastatic pancreatic cancer (SONAR trial) • CD44 as a biomarker in hepatocellular carcinoma • First-line regimens in advanced pancreatic cancer (SLOG vs mFOLFIRINOX) • Single-cell atlas of the colorectal cancer tumor microenvironment Together, these posts reflect a clear shift toward biologically informed, patient-centered, and durable treatment strategies shaping GI oncology in 2026. 👉 Read the full article -> https://lnkd.in/dJTtuURN #GIOncology #ColorectalCancer #PancreaticCancer #HepatocellularCarcinoma #ClinicalTrials Moawia Mohammed Ali Elhassan Oliver Waidmann Jan Henrik Klug Blerina Aliraj Lucía Alcober Boquet, PhD Dr. med. Dominic Denk, MHBA Lena Germann Nadja Meindl-Beinker Carolina De La Torre Prof. Dr. med. Fabian Finkelmeier Univ. Prof. Dr. Dr. med Thomas Vogl smolenschi cristina Alice Boilève ,Maxime Rémond Mathias Brugel Anthony Turpin Michel Ducreux Nelson Dusetti Ismail Gogenur Mikail Gögenur Camilla Qvortrup Jens Winther Jensen Jesper Fisker Bjerregaard Jon Kroll Giovanni Marchegiani Akshaya Srikanth, PhD Erman Akkus Stefan Salcher